Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio
Go back to Prolynx Names Simon Harnest as Chief Financial Officer and Amer Mirza, PhD, as Chief Scientific Officer as It Advances Multi-Program Obesity and Metabolic Disease Portfolio| (NASDAQ: CLLS) | Delayed: 1.56 +0.05 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.51 | 52 Week High | $37.55 | |||
| Open | $1.53 | 52 Week Low | $16.35 | |||
| Day High | $1.62 | P/E | N/A | |||
| Day Low | $1.53 | EPS | $0.00 | |||
| Volume | 76,319 | |||||
| Ram Gold & Exploration, Inc. (NASDAQ: MGX) | Delayed: 1.14 +0.02 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.12 | 52 Week High | $0.65 | |||
| Open | $1.07 | 52 Week Low | $0.65 | |||
| Day High | $1.16 | P/E | N/A | |||
| Day Low | $1.07 | EPS | $0.00 | |||
| Volume | 165,230 | |||||
